Purchase Order 75N92023P00037
Award Date
12/9/22
Potential Completion Date
12/8/27
Potential Value
$372K
Funding Federal Agency
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
Contracting Federal Agency
National Heart Lung and Blood Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
513210 - Software Publishers
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute to Illumina, Inc., a manufacturer of genomics analysis instruments and reagents. The contract is for a $277,908.00 annual subscription to the Illumina BaseSpace Clarity LIMS software to support the research efforts of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Intramural Research...
This is a firm fixed-price delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. for $101,126.67. The contract is for the provision of Illumina's proprietary genomic sequencing systems, reagents, and related services to support NIAMS's research and diagnostic needs. Illumina has a history of providing similar products and services to other federal...
This is a federal contract award to Illumina, Inc., a manufacturer of genetic sequencing and genomic analysis solutions, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH). The $199,073.27 firm-fixed price Delivery Order contract is for the provision of sequencing systems, reagents, and related services to support genomic research and diagnostics. This award was not subject to small business set-aside...
This is a delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic and genomic analysis instruments and reagents. The $243,600.00 firm fixed price contract has a completion date of September 2, 2025 and is not a set-aside award. Illumina has provided various sequencing systems, reagents, and bioinformatics products to support genomic research and analysis across multiple...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $144,182.10 contract is to provide Illumina sequencing systems, reagents, and related products and services to support genomic research and analysis at the NIH. Illumina has a history of...
This is a firm fixed price delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the Department of Health and Human Services, to Illumina, Inc. The contract, valued at $93,450.56, is for the provision of customized HiSeq sequencing kits to support genomic research across all NIAMS Intramural Research Program (IRP) laboratories. Illumina is a manufacturer of genomic sequencing instruments and reagents, and...
This is a firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. for $89,483.32. The award does not have a set-aside designation. Illumina, a manufacturer of genetic sequencing and analysis instruments and reagents, is providing goods and services to support genomic sequencing and analysis for research and diagnostic purposes. This order is...
This is a firm fixed price delivery order awarded to Illumina, Inc. by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH). The $92,732.07 contract provides Illumina's sequencing systems, reagents, and bioinformatics products to support genomic sequencing and analysis for research and diagnostic purposes. This delivery order is part of a larger indefinite delivery contract that Illumina holds with the...
This firm fixed-price delivery order was awarded to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH). The $249,573.07 award does not have a set-aside designation. Illumina has previously received prime federal contracts and subcontracts from agencies such as the NIH, CDC, USDA, and VA to provide their sequencing...
This is a firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The contract has a ceiling value of $248,907.23 and runs through September 2025. There is no set-aside designation. Illumina will provide a range of its sequencing systems, consumables, and bioinformatics products to support genomic research and...